Trupanion (NASDAQ:TRUP) had its price target increased by research analysts at Canaccord Genuity from $58.00 to $62.00 in a research report issued on Wednesday, BenzingaRatingsTable reports. The firm currently has a "buy" rating on the financial services provider's stock. Canaccord Genuity's price target would indicate a potential downside of 0.08% from the company's previous close.
Several other equities research analysts have also recently commented on the company. Lake Street Capital increased their price objective on Trupanion from $50.00 to $67.00 and gave the company a "buy" rating in a research report on Wednesday. Northland Securities lowered Trupanion from an "outperform" rating to a "market perform" rating and lifted their target price for the company from $42.00 to $50.00 in a research report on Wednesday. They noted that the move was a valuation call. BidaskClub raised shares of Trupanion from a "buy" rating to a "strong-buy" rating in a research report on Thursday, June 18th. Zacks Investment Research lowered Trupanion from a "hold" rating to a "sell" rating in a report on Saturday. Finally, Royal Bank of Canada restated a "buy" rating and issued a $40.00 price target on shares of Trupanion in a research report on Monday, June 15th. One research analyst has rated the stock with a sell rating, four have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. The company currently has a consensus rating of "Buy" and an average target price of $45.63.
TRUP traded up $9.23 on Wednesday, reaching $62.05. The company had a trading volume of 24,602 shares, compared to its average volume of 321,303. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.69 and a current ratio of 1.69. The company's fifty day moving average is $45.44 and its 200 day moving average is $34.29. Trupanion has a fifty-two week low of $20.84 and a fifty-two week high of $53.87. The stock has a market cap of $2.17 billion, a P/E ratio of -1,232.80 and a beta of 1.60.
Trupanion (NASDAQ:TRUP) last announced its earnings results on Tuesday, August 4th. The financial services provider reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.05. Trupanion had a negative return on equity of 1.23% and a negative net margin of 0.40%. The company had revenue of $117.92 million for the quarter, compared to analyst estimates of $114.63 million. During the same quarter in the prior year, the company earned ($0.06) EPS. The firm's revenue for the quarter was up 27.9% compared to the same quarter last year. On average, sell-side analysts expect that Trupanion will post -0.04 EPS for the current year.
In other news, CFO Tricia Plouf sold 7,044 shares of the firm's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $31.00, for a total value of $218,364.00. Following the completion of the sale, the chief financial officer now owns 5,656 shares of the company's stock, valued at approximately $175,336. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Asher Bearman sold 2,000 shares of the firm's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $30.37, for a total value of $60,740.00. Following the completion of the transaction, the insider now owns 10,422 shares of the company's stock, valued at approximately $316,516.14. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 74,150 shares of company stock worth $3,072,568. 11.28% of the stock is owned by insiders.
A number of hedge funds have recently added to or reduced their stakes in TRUP. Clarius Group LLC acquired a new position in Trupanion during the second quarter worth approximately $205,000. State Street Corp raised its stake in Trupanion by 0.7% during the first quarter. State Street Corp now owns 577,666 shares of the financial services provider's stock worth $15,037,000 after purchasing an additional 3,792 shares during the period. BNP Paribas Arbitrage SA increased its position in shares of Trupanion by 110.5% in the first quarter. BNP Paribas Arbitrage SA now owns 8,923 shares of the financial services provider's stock worth $232,000 after acquiring an additional 4,684 shares in the last quarter. Capital World Investors grew its stake in shares of Trupanion by 8.1% during the first quarter. Capital World Investors now owns 2,795,507 shares of the financial services provider's stock valued at $72,767,000 after acquiring an additional 210,000 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Trupanion by 183.1% during the 1st quarter. Victory Capital Management Inc. now owns 48,230 shares of the financial services provider's stock worth $1,255,000 after buying an additional 31,192 shares during the last quarter. Institutional investors own 92.71% of the company's stock.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Story: Different Options Trading Strategies
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
15 REITS Analysts Can't Stop Recommending
There are more than 200 publicly-traded real-estate investment trusts (REITs) that you can buy through your brokerage account. Given the sheer number of REITs, it can be hard to identify which real-estate stocks are going to outperform the market.
Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 4,000 distinct recommendations for REITs. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same REIT.
This slide show lists the 15 REITs that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "15 REITS Analysts Can't Stop Recommending".